KURA
NASDAQ · Biotechnology
Kura Oncology Inc
$9.57
+0.29 (+3.13%)
Open$9.37
Previous Close$9.28
Day High$9.60
Day Low$9.34
52W High$12.49
52W Low$5.45
Volume—
Avg Volume1.25M
Market Cap846.46M
P/E Ratio—
EPS$-3.35
SectorBiotechnology
Analyst Ratings
Strong Buy
22 analysts
Price Target
+379.8% upside
Current
$9.57
$9.57
Target
$45.92
$45.92
$25.11
$45.92 avg
$52.51
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 72.31M | 146.41M | 142.51M |
| Net Income | -298,601,529 | 21.31M | 25.50M |
| Profit Margin | -413.0% | 14.6% | 17.9% |
| EBITDA | -324,239,698 | 41.90M | 41.44M |
| Free Cash Flow | — | 24.20M | 22.28M |
| Rev Growth | — | -6.0% | +22.0% |
| Debt/Equity | 0.06 | 0.38 | 0.34 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |